Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Blackstone (BX) is mulling strategic options, including a sale, for mobile app marketing provider Liftoff that could value the company at over ...

In a report released today, William Katz from TD Cowen maintained a Buy rating on Blackstone Group (BX – Research Report), with a price target ...